Skip to content
BiologicalX

Comparison

Low-Dose Naltrexone vs N-Acetyl Cysteine

Side-by-side of Low-Dose Naltrexone and N-Acetyl Cysteine. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Low-Dose Naltrexone

  • Off-label use at 1.5 to 4.5 mg, roughly one-tenth the FDA-approved 50 mg addiction-treatment dose
  • Proposed mechanisms include brief opioid receptor blockade triggering rebound endogenous opioid release, plus TLR4 antagonism
  • Compounded prescription only; insurance rarely covers; cash prices 20 to 80 USD per month
  • Younger 2013 reported ~30% pain reduction in fibromyalgia at 4.5 mg in a small crossover trial
  • Smith 2011 reported endoscopic improvement in active Crohn's disease (n=40 placebo-controlled)
  • Vivid dreams affect 20 to 40% in first 2 weeks; manageable by switching to morning dosing

N-Acetyl Cysteine

  • Replenishes intracellular glutathione by supplying cysteine, the rate-limiting amino acid for synthesis
  • First-line antidote for acetaminophen toxicity, restoring hepatic glutathione before fulminant injury occurs
  • Reduces sputum viscosity in chronic bronchitis and COPD at 600 to 1200 mg/day over months
  • Modest symptom reductions in OCD and trichotillomania at 1200 to 2400 mg/day across small RCTs
  • Mixed evidence for psychiatric adjunct use in bipolar depression and schizophrenia negative symptoms
  • Inhaled forms can trigger bronchospasm in active asthma; oral use is the standard biohacker route

Side-by-side

Attribute Low-Dose Naltrexone N-Acetyl Cysteine
Category pharmaceutical supplement
Also known as LDN, naltrexone (low dose) NAC
Half-life (hr) 4 5.6
Typical dose (mg) 4.5 1200
Dosing frequency once daily, typically at bedtime 1 to 3 times daily, split dosing preferred
Routes oral oral, iv
Onset (hr) 1 1
Peak (hr) 1.5 2
Molecular weight 341.4 163.19
Molecular formula C20H23NO4 C5H9NO3S
Mechanism Brief mu-opioid receptor antagonism proposed to trigger compensatory upregulation of endogenous opioids; secondary TLR4 antagonism on microglia and immune cells contributes to anti-inflammatory effect. Deacetylated to cysteine, the rate-limiting precursor for glutathione synthesis; also directly scavenges reactive oxygen species and modulates glutamate signaling.
Legal status Off-label compounded prescription (naltrexone is FDA approved for opioid and alcohol use disorder at 50 mg) OTC in most jurisdictions; restricted periods in US history (FDA reclassified 2022)
WADA status allowed allowed
DEA / Rx Rx only (not a controlled substance) OTC supplement (US, post-2022); Rx indications also exist (acetaminophen overdose, mucolytic)
Pregnancy Insufficient data; not routinely recommended Used clinically in pregnancy for specific indications; consult clinician
CAS 16590-41-3 616-91-1
PubChem CID 5360515 12035
Wikidata Q426444 Q413299

Safety profile

Low-Dose Naltrexone

Common side effects

  • vivid dreams
  • sleep disruption
  • headache
  • mild GI upset
  • fatigue (early)

Contraindications

  • concurrent opioid use
  • acute hepatitis or liver failure
  • opioid dependence
  • pregnancy (insufficient data)

Interactions

  • opioid analgesics (oxycodone, morphine, codeine): blocks analgesic effect; precipitates withdrawal in dependent users(major)
  • tramadol: blocks opioid component of analgesia(major)
  • thyroid hormone replacement: may alter dose requirements after immune modulation; monitor TSH(minor)

N-Acetyl Cysteine

Common side effects

  • sulfur-like taste or odor
  • nausea
  • flatulence
  • diarrhea

Contraindications

  • active asthma attack (inhaled form can trigger bronchospasm)
  • known NAC hypersensitivity

Interactions

  • nitroglycerin: potentiates vasodilation, risk of hypotension and headache(moderate)
  • activated charcoal: reduces NAC absorption when used for acetaminophen overdose(moderate)
  • anticoagulants: theoretical additive antiplatelet effect at high doses(minor)

Which Should You Take?

N-Acetyl Cysteine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC, oral dosing, with a Tier-A outcome catalogued. Low-Dose Naltrexone is the right call when one of the conditionals below applies.

Edge case: If you want to avoid prescription-only, N-Acetyl Cysteine is the more accessible choice.

Default choice: N-Acetyl Cysteine. Wider use case, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Low-Dose Naltrexone only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Low-Dose Naltrexone and N-Acetyl Cysteine?

Low-Dose Naltrexone and N-Acetyl Cysteine differ in category (pharmaceutical vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Low-Dose Naltrexone or N-Acetyl Cysteine?

Low-Dose Naltrexone half-life is 4 hours; N-Acetyl Cysteine half-life is 5.6 hours.

Can you stack Low-Dose Naltrexone with N-Acetyl Cysteine?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper